Influence on consumer behavior: The impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder

Journal of Health Communication

Volumn 14, Issue 5, 2009, Pages 451-460

  Khanfar, Nile M ^a   Polen, Hyla H ^a   Clauson, Kevin A ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTILIPEMIC AGENT; ESOMEPRAZOLE; FLUOXETINE; LANSOPRAZOLE; NOSE SPRAY; PANTOPRAZOLE; PAROXETINE; PROTON PUMP INHIBITOR; SERTRALINE;

ADULT; ADVERTIZING; ARTICLE; CONSULTATION; CONSUMER; DRUG COST; DRUG MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HEARTBURN; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; MEDICAL INFORMATION; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL PHOBIA; TELEVISION;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGED; ANTI-ANXIETY AGENTS; ANTI-ULCER AGENTS; ANXIETY DISORDERS; FEMALE; FLORIDA; GASTROESOPHAGEAL REFLUX; HEALTH BEHAVIOR; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMP INHIBITORS; QUESTIONNAIRES; TELEVISION; UNITED STATES; YOUNG ADULT;

EID: 68649087164     PISSN: 10810730     EISSN: 10870415     Source Type: Journal    
DOI: 10.1080/10810730903032978     Document Type: Article

References (26)

1. Advertising Age. (2008). Data Center.100 Leading national advertisers. Retrieved June 27, 2008, from http://adage.com/datacenter/article?article-id= 127791.
2. Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs - Summary of FDA survey research results. Retrieved February 24, 2008, from http://www.fda.gov/cder/ddmac/Final%20Report/FRFinalExSu1119042.pdf
3. Atherly, A., & Rubin, P. H. (2008). The cost effectiveness of direct to consumer advertising for prescription drugs. Retrieved February 26, 2008, from http://papers.ssrn.com/sol3/papers.cfm?abstract-id=1092164#PaperDownload
4. Auton, F. (2006). Direct-to-consumer advertising (DTCA) of pharmaceuticals: An updated review of the literature and debate since 2003. Economic Affairs, 26(3), 24-32.
5. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651-657.
6. Bonaccorso, S. N., & Sturchio, J. L. (2002). Direct to consumer advertising is medicalising normal human experience. British Medical Journal, 324, 910-911. (Pubitemid 34303949)
7. Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Williams, M. V., & Parker, R. M. (2004). Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9(6), 491-497.
8. Calfee, J. E. (2007). An assessment of direct-to-consumer advertising of prescription drugs. Clinical Pharmacology and Therapeutics, 82(4), 357-360. (Pubitemid 47414364)
9. Datti, B., & Carter, M. W. (2006). The effect of direct-to-consumer advertising on prescription drug use by older adults. Drugs & Aging, 23(1), 71-81. (Pubitemid 43290886)
10. Donohue, J. (2006). A history of drug advertising: The evolving roles of consumers and consumer protection. The Milbank Quarterly, 84(4), 659-699.
11. Dutta-Bergman, M. J. (2004). Health attitudes, health cognitions, and health behaviors among Internet health information seekers: Population-based survey. Journal of Medical Internet Research, 6(2), e15.
12. Findlay, S. D. (2002). DTC advertising: Is it helping or hurting? Statement before the Federal Trade Commission, National Institute of Health Care Management (NIHCM) Foundation. Available at http://www.ftc.gov/ogc/healthcare/ findlay.pdf
13. Holmer, A. F. (1999). Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Journal of the American Medical Association, 281(4), 380-382. (Pubitemid 29061046)
14. Holmer, A. F. (2002). Direct-to-consumer advertising - strengthening our health care system. The New England Journal of Medicine, 346(7), 526-528.
15. IMS Health (2007). Top line industry data: Total U.S. promotional spend by type, 2006. Retrieved January 24, 2008, from http://imshealth.com/ims/portal/ front/articleC/0,2777,6599-80402580-814932500.html
16. Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., & Franks, P. (2005). Influence of patients' requests for direct-to consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293(16), 1995-2002. (Pubitemid 40570893)
17. Mintzes, B., Barer, M. L., Kravitz, R. L., Kazanjian, A., Bassett, K., Lexchin, J., Evans, R. J., Pan, R., & Marion, S. A. (2002). Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: Two sites cross sectional survey. British Medical Journal, 324, 278, 279. (Pubitemid 34121841)
18. Mintzes, B., Barer, M. L., Kravitz, R. L., Bassett, K., Lexchin, J., Kazanjian, A., Evans, R. J., Pan, R., & Marion, S. A. (2003). How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Association Journal, 169(5), 405-412. (Pubitemid 37076252)
19. Murray, E., Lo, B., Pollack, L., Donelan, K., & Lee, K. (2004). Direct-to-consumer advertising: Public perceptions of its effects on health behaviors, health care, and the doctorpatient relationship. The Journal of the American Board of Family Practice, 17(1), 6-18.
20. Robinson, A. R., Hohmann, K. B., Rifkin, J. I., Topp, D., Gilroy, C. M., Pickard, J. A., & Anderson, R. J. (2004). Direct-to-consumer pharmaceutical advertising: Physician and public opinion and potential effects on the physician-patient relationship. Archives of Internal Medicine, 164, 427-432. (Pubitemid 38240707)
21. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. J., & Epstein, A. M. (2002). Promotion of prescription drugs to consumers. New England Journal of Medicine, 346(20), 498-505.
22. Spence, M. M., Teleki, S. S., Cheetham, T. C., Schweitzer, S. O., & Millares, M. (2005). Direct-to-consumer advertising of COX-2 inhibitors: Effect on appropriateness of prescribing. Medical Care Research and Review, 62(5), 544-559.
23. Spooner, T., Meredith, P., & Rainie, L. (2003). Pew Internet & American Life Project. America's online pursuits: The changing picture of who's online and what they do. Retrieved June 27, 2008, from http://www.pewinternet. org/pdfs/PIP-Online-Pursuits-Final.PDF
24. United States General Accounting Office. (2002). Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. Report No. 03-177. Retrieved February 26, 2008, from http://www.gao.gov/new.items/d03177.pdf
25. Weissman, J. S., Blumenthal, D., Silk, A. J., Newman, M., Zapert, K., Leitman, R., & Feibelmann, S. (2004). Physicians report on patient encounters involving direct to-consumer advertising. Health Affairs, W4, 219-233. (Pubitemid 39302585)
26. Weissman, J. S., Blumenthal, D., Silk, A. J., Zapert, K., Newman, M., & Leitman, R. (2003). Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs, W3, 82-95.